As the regenerative medicine field rapidly evolves, CIRM faces a key challenge: investing the remaining $3.86 billion in ways that deliver the greatest impact for Californians.
To meet this challenge, CIRM launched the Strategic Allocation Framework (SAF) to prioritize resources and maximize the potential of regenerative medicine breakthroughs.
What is the SAF?
The SAF uses a systematic, data‑driven approach to help CIRM prioritize how to use its resources most effectively. It guides recommendations to the Independent Citizens’ Oversight Committee, ensuring CIRM stays aligned with its strategic goals and maximizes its impact on Californians.pact on the lives of Californians.
Goals Designed for Maximizing Impact
For nearly a year, CIRM has built the SAF around impact goals that reflect its commitment to accelerating treatment development, promoting equitable access, fostering scientific collaboration, and building the future workforce.
Watch our board and subcommittee recordings to learn more about each goal and the related recommendations.
- June ICOC – Background & SAF Overview
- July Science Subcommittee / Neuro Task Force – Goals 1 & 2
- August Science Subcommittee / Neuro Task Force – Goals 3 & 4
- September Science Subcommittee / Neuro Task Force – Goals 5 & 6
As CIRM advances the SAF, we invite you to learn more about our new direction. CIRM’s public posting includes details on key recommendations.
The Board will discuss these goals and final recommendations on September 26, 2024, when it will decide the future direction of CIRM’s funding.
For more information about the upcoming Board meeting, visit our Public Meetings and Events page.
Related Posts
CIRM Recommendations from Strategic Allocation Framework